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Aluminum alters calcium influx and efflux from bone in vitro
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Medical and Research Services, Sepulveda Veterans Administration Medical Center, Sepulveda, and UCLA School of Medicine/San
Fernando Valley Program, Los Angeles, California, USA
Aluminum alters calcium influx and efflux from bone in vitro. Alumi-
num retention can cause osteomalacia and adynamic lesions of bone in
patients undergoing long-term dialysis. It is not known, however,
whether aluminum inhibits the mineralization of bone directly or
whether alterations in osteoblastic function mediate this response. To
examine this issue, the uptake of 45Ca by 14-day embryonic chick
calvaria was measured in vitro. Comparative studies were done in living
and devitalized tissues to evaluate the role of bone cells in aluminum-
related changes in 45Ca uptake. Aluminum was added to serum-free
media as the citrate complex, and paired hemicalvaria maintained in
equimolar sodium citrate served as controls. Aluminum citrate de-
creased the uptake of 45Ca into bone during 24 hour incubations to 76
3% and 38 2% (x SD) of control values at 10 /LM and 100 zM
aluminum, respectively. No change in 45Ca uptake was observed at the
end of four hour incubations with 100 M aluminum citrate, whereas
45Ca uptake decreased from 356 48 to 266 36 cpm/g bone, P <
0.05, at eight hours and from 327 22 to 269 41 cpm/g bone, P <
0.05, at 24 hours. The inhibitory effects of 10 jiM and 100 jiM aluminum
on 45Ca uptake were eliminated, however, in devitalized tissues, and
reductions in 45Ca uptake during incubations with aluminum were
markedly attenuated by lowering the media phosphorus level from 4.0
m to 2.0 m. In separate studies, both 10 jiM and 100 jiM aluminum
increased 45Ca release from live calvaria by 62 6% and 73 4%,
respectively, during 24 hour incubations; this response was only
partially blunted in devitalized bones. The results suggest that bone
cells participate in aluminum-induced reductions in tissue calcification
in vitro. Aluminum may also enhance calcium mobilization from bone
by a cell-independent mechanism.
Aluminum retention in the body has been implicated in the
pathogenesis of osteomalacia and adynamic lesions of bone in
patients with chronic renal failure undergoing long-term dialysis
as well as in other patients with evidence of aluminum deposi-
tion in tissues [1—6]. Several studies in humans and experimen-
tal animals indicate that aluminum disrupts skeletal mineraliza-
tion and reduces the number and activity of osteoblasts [7—111.
It is not known, however, whether the inhibitory actions of
aluminum are direct or whether changes in osteoblastic function
account for this disturbance [11, 12].
Several in vitro studies have suggested that aluminum has
direct inhibitory effects on calcification. Using a cell-free in
vitro system, Blumenthal and Posner demonstrated that the
addition of aluminum to aqueous solutions reduced hydroxyap-
atite crystal seeding and growth [13]. Similarly, Meyer and
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Thomas noted that increasing concentrations of aluminum
citrate lowered the rate of formation of calcium-phosphate
crystals in solution [14]. Although such data indicate that
aluminum can influence the physical-chemical process of calci-
fication in situ, similar effects have yet to be demonstrated in
intact tissues. Indeed, previous assessments of in vitro miner-
alization in embryonic chick calvaria indicate that collagen
synthesis also decreases substantially during incubations with
aluminum [15, 16]; thus aluminum-related changes in the rate of
collagen production by osteoblasts may contribute to impaired
calcium uptake by viable tissues [17].
To further examine the role of osteoblasts in aluminum-
related changes in calcium uptake by intact tissues, studies
were done in both living and devitalized fourteen-day, embry-
onic chick calvaria. The results suggest that bone cells and
physical-chemical factors each contribute to alterations in cal-
cium influx into and efflux from bone during incubations with
aluminum.
Methods
Technique of tissue culture
Fourteen-day embryonic chick calvaria were used for all in
vitro experiments. Fresh, fertile eggs (Long Island Red, Shel-
ton's Poultry, Pomona, California, USA) were incubated at
100°F in a humidified environment (Roll-X Automatic Incuba-
tor, Marsh Farms, Garden Grove, California, USA) for 14 days
at which time the embryos were harvested. Both hemicalvaria
were removed by blunt dissection under sterile conditions in a
laminar flow hood. Bones were freed of adherent soft tissue and
kept in sterile Hanks balanced salt solution (HBSS) until the
start of experimental procedures [18, 19]. Only intact, paired
hemicalvaria were used for study; bones damaged during re-
moval from the embryos were discarded.
Calvaria were maintained in tissue culture at 37°C under a
moist atmosphere of 95% air/5% carbon dioxide. The tissues
were floated on sterile lens paper rafts in individual wells of 24
multiwell plates (Corning) containing two milliliters of serum-
free BGJ medium (Fitton-Jackson modification) (Sigma Chem-
ical Co., St. Louis, Missouri, USA) [18, 19]. Supplemental
phosphorus was added after reconstitution of powdered media
to achieve a final concentration of either 4.0 m or 2.0 mM;
these values were confirmed by measurements done on aliquots
of the medium obtained immediately after preparation and at
the end of incubations [20].
All experiments were done using serum-free media, and the
nutrient medium was changed every 24 hours. The viability of
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calvaria maintained in serum-free conditions for as long as 72
hours was documented in preliminary studies by measurements
of the incorporation of tritiated thymidine (3H-TdR) into DNA.
Preparation of devitalized calvaria
Devitalized chick calvaria were prepared by three passages
through a freeze-thaw cycle. After harvest from the embryos,
tissues were frozen at —20°C for 24 hours, then thawed at room
temperature for 24 hours fOr each cycle. Devitalized calvaria
exhibited no active DNA synthesis as judged by the incorpora-
tion of 3H-TdR into DNA during 24 and 48 hour incubations in
serum-free media.
Determinations of bone weight
At the conclusion of all incubations, calvaria were removed
from the culture medium, thoroughly rinsed three times in cold
HBSS, and extracted for 10 minutes in 100% ethanol. Tissues
were then dried in a vacuum desiccator for 48 hours, and the
weight of individual bones was determined using a Cahn mi-
crobalance (Cahn Instruments, Inc., Cerritos, California,
USA). Tissue samples were manipulated with instruments only,
and individual weighing boats were used for all determinations
of bone weight.
Measurements of radioactive calcium uptake
For all experiments, the uptake of 45Ca (5 to 30 Cl/gm, New
England Nuclear, Boston, Massachusetts, USA) into chick
calvaria was assessed during the final two hours of incubation;
45Ca, 2 Ci/ml, was added to serum-free medium 120 minutes
before the end of incubations, and tissues were removed from
the nutrient medium at the conclusion of the two-hour labeling
interval. After drying under vacuum, the dry weight of bones
was measured.
Tissues were then demineralized by immersion in one milli-
liter of 12.5% trichloroacetic acid (TCA) at 4°C for 24 hours; the
TCA extraction procedure was repeated for a second 24-hour
period to assure complete removal of all mineral, and the two
supernatant fractions were pooled. Total 45Ca activity was
measured by liquid scintillation spectrometry (Beckman Model
LS 1801, Beckman Instruments, Fullerton, California, USA) in
triplicate 0.5 milliliter aliquots of the pooled supernatant. All
values for 45Ca uptake are expressed in cpm//sg dry weight of
bone [18, 191.
Measurements of radioactive calcium release from bone
Calcium efflux from bone was assessed by measuring the
amount of 45Ca released into serum-free media from hemical-
varia that had been pre-labeled with 45Ca. Bones were labeled
with 45Ca by incubation overnight in media that contained 2
Ci' I of radioactive calcium. After labeling, the tissues were
kept for 24 hours in media that contained no radioisotope. The
culture media was then changed, and amount of 45Ca in fresh,
serum-free BGJ was determined by liquid scintillation spec-
trometry in 200 jd aliquots of media obtained after four, eight or
24 hours of incubation.
The total amount of 45Ca in the medium was calculated at
each interval. At the end of incubation, bones were dried under
vacuum, and the weights of the tissues were determined. All
results for 45Ca release from bone are expressed in cpm/tg dry
weight of bone.
Addition of aluminum to serum-free media
Because of the low solubility of aluminum in aqueous solu-
tions, aluminum was added to serum-free media as the citrate
complex. Stock solutions of aluminum citrate were prepared by
adding aluminum chloride to 3.0 mM and 30 m solutions of
sodium citrate at a molar ratio of 1:3. In preliminary studies, the
recovery of added aluminum from stock solutions and from
aluminum supplemented BGJ media exceeded 85%, and the
concentration of aluminum in various stock solutions of alumi-
num citrate remained constant for several months after prepa-
ration. The pH of serum-free medium was not affected by the
additions of sodium citrate or aluminum citrate, and there were
no differences in either total or ionized calcium levels in media
containing equimolar amounts of sodium citrate or aluminum
citrate.
Because of the potential for contamination with aluminum,
levels of aluminum in tissue culture media and reagents were
monitored regularly. The concentration of aluminum in all lots
of powdered BGJ media was measured after reconstitution, and
values were consistently below 3 sg/liter. Confirmation of
aluminum levels in media utilized in experiments was obtained
by measurements done on aliquots of serum-free BGJ obtained
at the end of incubations.
Biochemical measurements
Aluminum levels in tissue culture media, stock solutions and
reagents were determined using electrothermal atomic absorp-
tion spectroscopy [211. Calcium concentrations in nutrient
media were measured by atomic absorption spectroscopy, and
phosphorus levels were determined using colorimetric methods
[20, 22].
Statistical analysis
All results are presented as the mean standard deviation.
Data were evaluated using one way analysis of variance with
contrasts and the t-test for paired samples; the one-tailed t-test
was used to evaluate results expressed as a percentage of
control values [23].
Results
45Ca uptake into bone
In live calvaria grown for 24 hours in serum-free medium
containing 4.0 mM phosphorus, high concentrations of alumi-
num citrate reduced the uptake of 45Ca into bone compared to
paired hemicalvaria incubated with equal concentrations of
sodium citrate (Fig. 1). Values for 45Ca uptake decreased to 76
3% of control values at 10 ILM aluminum citrate and to 38
2% of control values at 100 tM aluminum citrate. In contrast,
neither 0.1 sM nor 1.0 M aluminum citrate altered 45Ca uptake
by the tissues (Fig. 1).
Reductions in 45Ca uptake during incubations with aluminum
were not due to changes in the level of calcium or phosphorus
in the nutrient medium following the addition of sodium citrate
or aluminum citrate; calcium and phosphorus levels in serum-
free BGJ did not differ across the range of concentrations of
sodium citrate and aluminum citrate utilized in these experi-
ments (Table 1). Moreover, the levels of calcium and phospho-
rus did not differ in serum-free medium containing equimolar
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Fig. 1. Effects of Na citrate (Li) and Al citrate () on 45Ca uptake by
embryonic chick calvaria at the end of 24 hour incubations in serum-
free medium containing 4.0 mM phosphorus. Values are means SD for
five paired hemicalvaria. *p < 0.01 vs. 10 /LM Na citrate; P < 0.01 vs.
100 sM Na citrate; J) < 0.05 vs. 0.1 sM Na citrate.
Table 1. Calcium and phosphorus levels in serum-free BGJ medium
containing 4.0 msi phosphorus and various concentrations of Na
citrate and Al citrate
Na citrate Al citrate
[Ca] [P1 [Cal [P1
1O M
10 M
l0— M
l0- M
Values
0.87 0.04
0.86 0.03
0.84 0.03
0.84 0.04
are means
4.03
4.01
4.01
4.02
standar
0.14
0.16
0.16
d deviation.
0.84 0.04
0.84 0.04
0.84 0.03
0.86 0.05
4.02 0.12
4.02 0.15
4.05 0.16
4.03±0.11
concentrations of sodium citrate and aluminum citrate (Table
I).
To determine whether physical-chemical factors known to
influence the rate of tissue calcification altered aluminum-
associated changes in in vitro calcium uptake into bone, live
calvaria were studied after 24 hours of growth in medium
containing 2.0 m phosphorus. As expected, lowering the
media concentration of phosphorus from 4.0 m to 2.0 mM
reduced the uptake of 45Ca into bone (Fig. 2). This change in
phosphorus concentration produced a modest reduction in the
calcium-phosphorus ion product in serum-free BGJ (Table 2). A
slight further decrease in 45Ca uptake was observed during
incubations with 10 /LM aluminum citrate, whereas 45Ca uptake
did not differ from control levels in the presence of 100 sM
aluminum citrate in calvaria grown in 2.0 m phosphorus (Fig.
2). Neither sodium citrate nor aluminum citrate altered the
calcium-phosphorus ion product in serum-free medium contain-
ing 2.0 m phosphorus (Table 2). Overall, the magnitude of
reduction in 45Ca uptake by live calvaria during incubations
with aluminum was less at media levels of 2.0 m phosphorus
than at 4.0 m phosphorus (Fig. 3).
The time course of the change in in vitro calcium uptake into
bone during incubations with aluminum was examined in live
calvaria by measuring the amount of 45Ca in bone at the end of
four, eight and twenty-four hour incubations in serum-free
medium containing 4.0 mit phosphorus (Figs. 4A and 4B). No
change in 45Ca uptake was evident at four hours, whereas
values decreased at eight and twenty-four hours in calvaria
Fig. 2. Effects of Na citrate and Al citrate on 45Ca uptake by live
hemicalvaria at the end of 24 hour incubations in serum-free medium
containing2.0 mM phosphorus. Symbols are: (D)4 msi P; () 2mM P.
Values are means SD for six paired hemicalvaria; < 0.01 vs. 2.0
m P control; tP < 0.01 vs. 4.0 ms P control.
incubated with 100 M aluminum citrate (Fig. 4B). The uptake
of 5Ca was also lower at the end of eight hour incubations with
10 fsM aluminum citrate (Fig. 4A). In contrast, reductions in
45Ca uptake after 24 hour incubations with aluminum citrate
were eliminated in devitalized tissues; neither 10 LM nor 100 /LM
aluminum citrate reduced the uptake of 45Ca into devitalized
hemicalvaria when compared to devitalized bones incubated
with sodium citrate (Fig. 4).
45Ca release from bone
To determine whether aluminum influenced the rate of cal-
cium efflux from bone, the amount of 45Ca released into
serum-free BGJ medium was measured both in live and in
devitalized hemicalvaria prelabeled with 45Ca. Prelabeled cal-
varia were incubated for 24 hours in media containing 10 p.M or
100 p.M sodium citrate or aluminum citrate, and the amount of
45Ca present in the medium was determined at four, eight and 24
hours.
Although the release of 45Ca from bone did not differ from
control values after four or eight hours incubations in live
hemicalvaria, 45Ca efflux increased after 24 hours in bones
incubated with 10 p.M or 100 /LM aluminum citrate (Fig. 5A)
Devitalization of the tissues failed to eliminate this response;
thus, both 10 p.M and 100 p.M aluminum citrate enhanced the
release of 45Ca from devitalized hemicalvaria during 24 hour
incubations (Fig. 5B).
Discussion
The results of the current study indicate that aluminum
reduces the rate of in vitro calcium uptake by live embryonic
chick calvaria during short-term incubations in serum-free
medium. In bones studied at normal media levels of phospho-
rus, calcium uptake decreased substantially at aluminum con-
centrations above 10 /hM, and these changes could not be
ascribed to reductions in the media concentrations of either
calcium or phosphorus. In contrast, lowering the concentration
of phosphorus in serum-free medium diminished the inhibitory
effect of aluminum on 4Ca uptake. Since calcification in
embryonic chick calvaria is largely due to the passive uptake of
calcium and phosphorus into bone, the current experimental
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Table 2. Calcium and phosphorus levels in serum-free BGJ medium containing 4.0 mri phosphorus and in medium containing 2.0 mM
phosphorus with and without Na citrate and Al citrate
Control
4mMP
Low P
2rnMP
NaCit AlCit NaCit AlCit
2mMPl0M, 2mMP l00/M,
Calcium mst 0.87 0.04 1.61 0.02 1.61 0.02 1.59 0.02 1.61 0.03 1.59 0.02
Phosphorus mzs 4.05 0.18 2.02 0.11 1.97 0.10 1.98 0.11 2.00 0.13 2.03 0.11
[Ca] x [P] ion product m 3.52 0.22 3.26 0.18 3.17 0.16 3.15 0.17 3.22 0.19 3.22 0.16
Values are means standard deviation.
Fig. 3. Effect of 10 jiM and 100 p.M Al citrate on 45Ca uptake by live
embryonic chick calvaria at the end of 24 hour incubations in serum-
free medium containing either 4.0 msi (U) or 2.0 mM () phosphorus.
Values are means SD. Results are expressed as a percentage of
control values determined in paired hemicalvaria incubated with equi-
molar Na citrate. *D < 0.05; ** < 0.01
results suggest that aluminum influences the physical-chemical
components of calcification in intact tissues. However, devital-
ization of the tissues markedly attenuated aluminum-associated
decreases in calcium uptake into bone, and this finding suggests
that bone cells also participate in reductions in tissue calcifica-
tion during incubations with aluminum.
The current results utilizing intact calvaria in tissue culture
are similar to findings reported previously using a cell-free
system to evaluate the separate effects of aluminum and citrate
ions on the process of in vitro calcification [14, 24]. In the
studies of Meyer and Thomas citrate alone reduced the rate of
growth of calcium phosphate crystals in aqueous solution,
whereas further decreases in crystal growth were observed
when sodium citrate was replaced by equimolar concentrations
of aluminum citrate [14, 24]. In the current study, small
decreases in 45Ca uptake into bone were evident in live hemi-
calvaria incubated with I JiM and 10 JiM sodium citrate, but the
inhibitory effect of aluminum citrate on 45Ca uptake was con-
siderably greater than that of sodium citrate, particularly at the
highest concentrations tested. These changes were not related
to decreases in the media levels of calcium and phosphorus,
findings consistent with a direct physical-chemical effect of
aluminum on tissue calcification.
The results of experiments done at reduced media concentra-
tions of phosphorus also suggest that physical-chemical inter-
actions are an important determinant of the in vitro response to
aluminum. Lowering the level of phosphorus in serum-free
medium from 4.0 m to 2.0 m decreased the uptake of 45Ca by
live calvaria, findings reported previously by others [25], This
change was due, in part, to a fall in the calcium-phosphorus ion
Time, hours
Fig. 4. The uptake of Ca by live chick calvaria after 4, 8 and 24 hours
incubations with either 10 p.M (A) or 100 p.M (B) Na citrate or Al citrate,
and values for 45Ca uptake at the end of 24 hours in devitalized bones
(Devitalized) studied concurrently. Symbols are: (U) 10 JiM Na; () 10
p.M Al; () 100 jiM Na; (171) 0100 p.M Al. Results are means SD for six
paired hemicalvaria. Probabilities represent comparisons at each point
between calvaria grown in equimolar concentrations of Al citrate and
Na citrate; *D < 0.05.
product in media containing 2.0 m phosphorus. Under these
conditions, the inhibitory effect of aluminum on 45Ca uptake
was less than that observed in bones grown in medium contain-
ing 4.0 m phosphorus. Thus, interactions between aluminum
and phosphorus may interfere with the physical-chemical driv-
ing forces which favor the uptake of calcium into bone.
Because a large component of calcium uptake in embryonic
chick calvaria is independent of bone cell viability [261, the
current findings are consistent with the view that aluminum
directly interferes with the formation and growth of hydroxy-
apatite crystals in bone during in vitro calcification. Recent
data, however, from studies of fetal rat calvaria in tissue culture
indicate that a substantial portion of the calcium taken up by
bone in vitro is incorporated into amorphous calcium and
phosphorus, particularly at high media concentrations of phos-
Time, hoursii
24 Devitalized8
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phorus [27]. In the current series of experiments, distinction
was not made between the formation of hydroxyapatite and the
deposition of amorphous calcium-phosphate in chick calvaria.
Nevertheless, it was expected that the physical-chemical ac-
tions of aluminum on in vitro 45Ca uptake would be demonstra-
ble at medium phosphorus levels of 4.0 m even in devitalized
tissues, regardless of the type of mineral ultimately deposited in
bone. Aluminum did not, however, reduce 45Ca uptake in
devitalized calvaria, whereas 45Ca uptake was lower than
control values in live, aluminum-treated calvaria studied con-
currently. Such findings suggest that the inhibitory effect of
aluminum on calcification in vitro is dependent, at least in part,
on the viability of bone cells.
The time course of the in vitro response to aluminum further
implicates bone cell activity as a modifier of tissue calcification
during incubations with aluminum. Reductions in 45Ca uptake
into bone were evident only following eight and 24 hours
incubations with aluminum citrate, whereas the uptake of 45Ca
did not differ from control values after four hour incubations.
These findings suggest that quantitative or qualitative alter-
ations in protein or collagen synthesis may be required for the
inhibitory actions of aluminum to become manifest.
Since reductions in 45Ca uptake into bone were observed only
at high media levels of aluminum, the relevance of the current
experimental findings to changes in in vivo mineralization must
be considered. In patients with aluminum-related bone disease,
basal serum aluminum levels usually exceed 2 M, or 54
Lg/liter, but values greater than 10 or 270 p,g/liter, are
uncommon [28, 29]. However, plasma aluminum levels do not
correlate well with the histologic severity of bone aluminum
toxicity, and plasma aluminum levels are generally imprecise
predictors of bone aluminum content [6, 28—31]. It is possible
that there are substantial differences between the concentration
of aluminum in plasma and that in the extracellular fluid of
bone; similar differences have been suggested with respect to
the concentrations of several other cations [32]. Relatively high
media concentrations of aluminum may be required, therefore,
during short-term in vitro studies to substantially influence the
ambient concentration of aluminum within the extracellular
fluid in bone.
In addition, all studies in the current series of experiments
were done in tissues maintained in serum-free medium. Recent
evidence from this laboratory suggests that the iron-transport
protein transferrin modifies the in vitro response of osteoblast-
like cells to several metals, including aluminum, gallium, and
iron [33]. The concentration of aluminum required to inhibit
DNA synthesis in UMR- 106-01 osteoblast-like cells is substan-
tially lower in cells grown in serum-free medium containing
physiologic levels of transferrin than in cells maintained without
transferrin [331. Since transferrin enhances the tissue and/or
cellular uptake of various metals [34], it is likely that higher
concentrations of aluminum are required during studies of
tissues maintained in serum-free medium to induce measurable
alterations in bone cell metabolism or in vitro calcium uptake.
The finding that aluminum increased the mobilization of
calcium from embryonic chick calvaria is of particular interest.
This response was partially independent of bone cell activity
since the amount of 45Ca released from bone during incubations
with aluminum was greater than control values both in living
and in devitalized tissues. Although aluminum has been re-
ported to reduce calcium efflux from hydroxyapatite crystals in
a cell-free system and to lower calcium release from mouse
embryonal forelimb rudiments in vitro [35, 36], the current
results suggest that aluminum promotes rather than inhibits the
mobilization of calcium from bone mineral in intact tissues.
These findings are in partial agreement with recent observa-
tions in studies of neonatal mouse calvaria [37]. In the report by
Sprague and Bushinsky, aluminum enhanced bone resorption
during 24 hour incubations in live calvaria [37]. In contrast to
the current findings, however, no change in calcium mobiliza-
tion from bone was observed in devitalized tissues exposed to
aluminum whereas calcitonin markedly attenuated the release
of calcium during incubations with aluminum [37]. Although
these observations, and the current experimental results, sug-
gest that changes in osteoclastic activity are at least partially
responsible for increases in calcium release from bone during in
vitro aluminum exposure, additional studies will be required to
determine whether such aluminum-related changes in bone
calcium effiux are mediated predominantly by cell-dependent or
cell-independent mechanisms.
In summary, aluminum alters the uptake of calcium into bone
as well as the release of calcium from bone in vitro. Aluminum-
associated reductions in calcium uptake by intact embryonic
chick calvaria are influenced by physical-chemical factors
known to affect the process of tissue calcification, but changes
in bone cell activity also represent a component of this re-
sponse. Aluminum may enhance calcium efflux from bone by a
mechanism independent of bone cell viability.
A 200
50
0
4 8 24
Time, hours
B 200
T
Time, hours
Fig. S. Effect of Al citrate on 45Ca release from bone in live (A) and
devitalized (B) chick calvaria during 24 hour incubations in serum-free
BGJ media, Symbols are: (-)control; (-Q-) 10 Al; (-4-) 100 5M Al.
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